The FANCM-RMI1/2 complex promotes genomic instability and PARP inhibitor sensitivity in BRCA2-deficicient cells.
François Dossin, Mikaël Attia, Fabricio Montero Zuniga, Daniel González‐Acosta, Rachel Brough, Fei Song, Dragomir B. Krastev, Maya Raghunandan, Stephen J. Pettitt, Aurélien Bore, Amaury Vaysse, Raphaël Margueron, Massimo Lopes, Andrew N.J. Tutt, Christopher J. Lord, Ludovic Deriano
This study identifies FANCM-RMI1/2 as a driver of PARP inhibitor sensitivity in BRCA2-deficient cells, revealing distinct adaptation mechanisms between BRCA1 and BRCA2 loss.
Molecular Cell · Oct 1, 2026Peer-reviewedCancer Biology